Clovis Oncology CLVS
$ 0.09
-7.23%
Quarterly report 2022-Q3
added 11-09-2022
Country |
USA |
IPO year |
2011 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Patrick Mahaffy |
Employees in the company |
484 |
Shares |
116 M |
Market Cap[1] |
$ 13 M |
EBITDA (LTM) |
$ -195 M |
P/E (LTM) |
-0.05 |
P/S (LTM) |
0.1 |
EPS (LTM) |
-1.83 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.